Respiratory Flashcards

1
Q

Where a.w smooth muscle extends to

A

Terminal bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SNS action and activation of which receptor

A

B2 adrenoreceptors mediate relaxation of smooth muscles in vessels, bronchi, uterus, bladder, and other organs. Activation= bronchodilation, increased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Non adrenergic, non cholinergic nerves

Do what to a/w

A

Relax smooth muscle by releasing NO and VIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PSNS
Action
Receptors
Pathway

A

Stim vagus leads to bronchoconstriction. M3 receptors are pharmacologically most imp. In bronchial muscle, mediate constriction by activ of IP3 which increases intracellular Ca. Mediates mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ANS impact on resp system through 2 things

A

Adrenergic B2: bronchial smooth muscle relaxation, bronchodilation
Cholinergic: smooth muscl contraction, increased gland secretion- constriction and inc mucus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Asthma results in what

S/s

A

Variable airflow obstruction that’s reversible.

Breathlessness, tight chest, wheeze, dyspnea, cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What you’re addressing w drugs in asthma

2 main classes

A

Inflammation and bronchoconstriction

  1. Anti-inflammatories- steroids, prednisone
  2. Bronchodilators- B2 agonists, albuterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which drugs taken for asthma daily for long term control

A
Anti inflammatories 
Inhaled corticosteroids 
Cromolyns 
Leukotriene inhibitors 
Anti IgE antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most important preventative tx for asthma

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glucocorticoids

MOA

A

Suppress inflammation by altering genetic transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glucocorticoids

Target

A

Glucocorticoids receptor alpha in cytoplasm of a/w epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glucocorticoid transcription effects: 3

A

Inc transcription of genes for: B2 receptors/responsiveness, anti-inflammatory proteins
Decreases transcription of genes for pro inflammatory proteins: decreases mucus production and edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Glucocorticoids

3 other effects than transcription

A

Induces apoptosis in inflammatory cells (eosinophils, th2, lymphocytes)
Indirect inhibition of mast cells over time
Reverses bronchial hyperreactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glucocorticoids
Use, what it doesnt do
Usual route

A

Suppressive therapy, not a cure

Inhalation. (IV and oral also available)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inhaled corticosteroids

Use

A

Long term prophylaxis in mod to severe asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhaled steroids

Which nebulized for who

A

Budesonide, kids too young to use MDI or DPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Inhaled steroids

4

A

Budesonide
Beclomethasone
Triamcinolone
Fluticasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IV steroids, use in asthma, 2

A

Hydrocortisone and methylprednisone, status asthmaticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Corticosteroids

PO- for what, 2 ex

A

Acute exac, chronic severe asthma.

Prednisone and prednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Inhaled corticosteroid
How much reaches airway, what increases concentration in lung
Conc in lung compared to PO
Adrenal suppression compared to PO/iv

A

10-20%, beta 2 agonist before inhalation
Higher
Mild

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Inhaled corticosteroid

Side effects

A

Candidiasis
Hoarseness
Delayed growth kids
Osteopenia/porosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Systemic corticosteroids AE
When minor
Long term effects

A

<10 days

Weakness, adrenal suppression, infection risk, growth suppression, PUD, wt gain, edema, hypokalemia, hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Systemic corticosteroids

Give extra when or what

A

IV or PO during physiologic stress (surgery, trauma, infection) or pt could die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Cromolyn

MOA

A

Stabilizes pulmonary mast cells. Inhibits antigen induced release of histamine, inflammatory mediators from: eos, neutro, mono, mac, lymph, Leuko. Inhib allergic response to antigen but not once its activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cromolyn

Principle use

A

Bronchial asthma prophylaxis, prevents exercise induced bronchospasm. Not a rescue inhaler.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cromolyn
Route
How much goes systemic
Take how often

A

Inhalation
8-10%
4 times daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Cromolyn
SE
Comparison to other asthma meds
Route

A

Cough, bronchospasm, laryngeal edema, angioedema, urticaria, anaphylaxis
Safest of them all, SE rare
Neb or MDI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Leukotriene modifiers

How leukotrienes are synthesized, which we’re concerned about and why

A

From Arachidonic acid when inflammatory cells are activated. C4, D4, E4. Promote bronchoconstriction, eosinophils, mucus, and airway edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Leukotriene modifiers
Comparison to glucocorticoids
Not effective for
Few what

A

Less effective
Acute attacks
Extrapulmonary effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Leukotriene modifiers

3 ex

A

Zyflo (zileuton)
Accolate (zafirlukast)
Montelukast/singular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Zileuton
Class
Action
Uses

A

Leukotriene inhib.
Lipoxygenase inhib, blocks leukotriene synth from arachidonic acid
Bronchodilation, for asthma, long term improvement PFT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Zileuton
Metab
AE

A
Low bioavailability and low potency 
Hepatotoxic- monitor LFT early 
Neuro: depression, anxiety, halluc, suicidal thinking 
Interacts w CYP450 
Not widely used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Montelukast

Action

A

Blocks bronchoconstriction and smooth muscle effects. Blocks binding to leukotriene 1 receptor. Improves bronchial tone, pulm function, and asthma symptoms

34
Q

Montelukast

Use in who

A

Asthma in <1 y/o, exercised induced bronchospasm >15 y/o, allergic rhinitis

35
Q
Montelukast 
Adverse effects 
Max effect when 
Metab
What inc drug level
A

Placebo, rare psych effects
24 hrs after 1st dose
99% protein bound, by cyp 450, minimal interactions
Phenytoin

36
Q

Omalizumab
Class
Target

A

Anti IgE antibodies. Mouse monoclonal antibody.

IgE mediated allergic responses in asthma

37
Q

Omalizumab

Action

A

Binds to IgE and inactivates it. Decreases overall amt, prevents IgE binding to mast cells. Down regulates receptors on mast/baso/dendritic cells. Reduces stim T2 lymph.

38
Q
Omalizumab 
Downside 
Route 
Taken when 
1/2 life
A

10k per year
Sq
Allergy induced asthma not tx by glucocorticoids
26 days

39
Q

Omalizumab

SE

A

Injection site rxn, viral infec, URI, sinusitis, HA, pharyngitis, CV (inc MI and CVA, HF, dysrhythmias, thromboembolism risk), possible inc risk cancer

40
Q

Omalizumab

Rare AE

A

Triggers anaphylaxis. Monitor 2 hrs after first three doses, then 30 min after all subsequent doses

41
Q

Bronchodilators

How they work

A

Symptomatic relief, dont tx underlying cause of inflammation.
Should also take glucocorticoids

42
Q

Bronchodilators

3 types

A

Beta adrenergic agonists
Anticholinergics
Methylxanthines

43
Q

B adrenergic agonists

MOA

A

B adrenergic receptors coupled to stim G proteins. Activate adenylyl cyclase which inc cAMP, then bronchodil. Dec Ca inc K. Dilates bronchi, smooth muscle relax, inhib mast cell and inc mucus clearance

44
Q

B adrenergic agonists

Most effective drugs for

A

Acute bronchospasm and prevention of exercise induced bronchospasm. Quick relief and long term control

45
Q

B adrenergic agonists
Receptor selectivity
Short v long acting types

A

B2 200-400x more than b1
Short: albuterol, levalbuterol
Long: salmetrol, terbutaline (po or iv)

46
Q

B adrenergic agonists
Onset
Routes

A

15-30 min. Short or long acting
Inhalation, aerosol
Powder, neb
Orally or sc

47
Q

B adrenergic agonists

SE

A

Minimized by inhalation route. Tremor, inc HR, vasodilation, hyperglycemia, hypokalemia, hypomagnesemia

48
Q

B adrenergic agonists

Oral preps excessive dose leads to

A

Angina and tacky dysrhythmias

49
Q

Albuterol

Doses

A

MDI: 100 mcg/puff. 2 puffs q4-6 h
Neb: 2.5-5 mg in 5 ml saline

50
Q

Albuterol
Duration
Isomers

A

4 hrs, up to 8 hrs.

R albuterol levalbuterol, more affinity B2.
S albuterol, more affinity b1.

51
Q

Metaproterenol
Indic
Route
Max dose

A

Beta 2 agonist for asthma. MDI

16 puffs a day

52
Q
Bitolterol 
Class 
Duration 
AE 
Dose
A

Selective B2 lasts longer than albuterol
Rare cv effects
Metered dose 16-20 puffs a day. Each dose 270 mcgs

53
Q

Terbutaline
Class
Routes
Indic

A

B adrenergic agonist
Oral, sc, inhalation
Treats asthma

54
Q
Terbutaline 
Sc admin resembles 
Sc dose peds 
Sc dose adults 
Medi dose and amt
A
Epi response 
0.1 mg/kg
0.25 mg q15 min 
16-20 puffs/day 
Each dose 200 mcgs
55
Q
Salmetrol 
Class 
Other drug like it 
Duration 
For what 
Warning
A

Formoterol. Long acting b agonist
12-24 h, lipophilic side chains
Prevention not flare up
May inc risk of fatal asthma attack

56
Q

Methylxanthines
Class
MOA

A

Bronchodilators, phosphodiesterase inhib
Unclear. May inhib pdi isoenxymes and prevent camp degred in airway. Anti inflammatory. Possible adenosine receptor block

57
Q

Methylxanthines
Drug effect
Clinical applic
Types

A

Airway relaxation and bronchodilation
COPD and asthma
Theophylline and aminophylline

58
Q
Methylxanthines 
Theophylline 
Downside 
Therap plasma level
When toxic 
1/2 life
A

Mult SE and narrow therapeutic index
10-20 mg/ml
>20 mg/ml
Wide variation, esp smokers who metab faster

59
Q

Methylxanthines

Drug interactions

A

Cimetidine, cipro, and antifungals inc levels (cp450 inhib)
Phenobarbital and phenytoin decrease levels
Caffeine can inc levels and be toxic to cns and cv

60
Q

Methylxanthines
Metab and excretion
Only in what form

A

Liver, kidney

Sustained release only

61
Q

Methylxanthines

SE

A

Cv arrhythmias
NV
Irritable, insomnia, seizures, brain damage, hyperglycemia, hypokalemia, hypotension,death from cv collapse

62
Q

Muscarinic receptor antagonists

MOA

A

Competitive antagonists at muscarinic acetylcholine receptors.
Promotes smooth musc relax and decreased mucus secretion

63
Q

Muscarinic receptor antag
Which subtype most imp
Uses

A

Muscarinic 3

Tx COPD, secondary line of tx for asthma in pts resistant to beta agonist or significant cv disease

64
Q

What m3 receptors do when stimulated

A

Drop inflammatory mediators

65
Q

Atropine
What it is
Indic
Dose

A

Naturally occurring alkaloid
Used to be 1st line for asthma
1-2 mg diluted in 3-5 ml saline via neb

66
Q

Atropine
Absorption
SE

A

Highly abs across respiratory epithelium

Systemic anticholinergic fx: tachycardia, nausea, dry mouth, gi upset

67
Q

Ipratropium bromide
What it is
What it does

A

Quaternary ammonium salt, deriv of atropine. Anticholinergic
Antagonists effect of ach at M3

68
Q
Ipratropium 
Dose 
Onset 
Duration 
Absorption
A

40-80mcg MDI or in 2-4 puffs via neb
30-90 min
4-6 hours
Not absorbed as well as atropine. Inadvertent oral abs can lead to gi upset and dry mouth

69
Q
Tiotropium 
What it is 
Class 
Absorption 
Approved for
A

Quaternary ammonium salt
Long acting anticholinergic
Not abs sig in resp epithelium, less SE
FDA approved for COPD

70
Q

Glucocorticoid/LAB2A combos
2 types
Indic for

A

Fluticason and salmetrol (advair)
Budesonide and formoterol (symbicort)
Long term maintenance in adults and kids. Reduces symptoms

71
Q

Glucocorticoid and LAB2A combos
Not for
Black box warning

A

Initial therapy. Many pts controlled on inhaled glucocorticoid
Asthma related death inc risk

72
Q

Lab2a stands for what

A

Long acting beta 2 agonist

73
Q

Asthma
Source of allergens
What can exac it

A

Dust mites, pets, cockroaches, mold

Tobacco Smoke, wood smoke, household sprays

74
Q

Drugs for severe asthma exac

A

Give o2 (hypoxia), Systemic glucocorticoid (inflam), neb high dose Saba (obstruc), neb ipratropium (obs)

75
Q

COPD
What drugs have ltd effect
What reduces exac freq
What modestly improves air outflow

A

Steroids
Inhaled corticosteroids
Bronchodilators- for pts w breathlessness worsened by exertion

76
Q

COPD

Monotherapy started which of 3

A

Long acting beta 2 (salmetrol)
Long acting anticholinergic (tiotropium)
Inhaled glucocorticoid (budesonide)
One of the 3. Bud- last choice

77
Q

COPD

If monotherapy doesnt work then what

A

Add a second class of drug. Usually laba and a steroid

78
Q

Roflumilast (daliresp)
For what
What it does

A

New COPD drug. Selective phosphodiesterase type 4 inhib, reduces exac

79
Q

Daliresp

Moa

A

Inc cAMP levels resulting in reduced cough, inflammation, and mucus

80
Q

Daliresp

SE

A

Diarrhea, wt loss, loss of appetite, nausea, HA, back pain, depression